No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Monday, June 22, 2026
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

Kohl’s FY25 profit rises despite lower net sales

by TheAdviserMagazine
3 months ago
in Business
Reading Time: 2 mins read
A A
Kohl’s FY25 profit rises despite lower net sales
Share on FacebookShare on TwitterShare on LInkedIn


US omnichannel retailer Kohl’s Corporation has reported higher operating and net income for fiscal year 2025 (FY25), even as net sales declined during the year.

For the year ending 31 January 2026, net sales fell 4% year-on-year (YoY) to $14.77bn, while comparable sales declined 3.1%.

Operating income for the year totalled $624m, up from $433m in the previous fiscal year.

Net income reached $272m, equivalent to $2.38 per diluted share. In the preceding fiscal year, the company recorded net income of $109m, or $0.98 per diluted share.

During the year, the retailer also recognised a $129m gain related to a legal settlement tied to a credit card interchange fee lawsuit.

In the fourth quarter, net sales decreased 3.9% YoY to $4.97bn while comparable sales declined 2.8%.

Operating income for the quarter rose to $212m from $126m in the same quarter in the previous year.

Net income came in at $125m, or $1.07 per diluted share, up from $48m, or $0.43 per diluted share, in the prior year’s quarter.

Kohl’s CEO Michael Bender said: “We are ending 2025 in a stronger position than we started, with important work still ahead of us. Over the past year, our efforts have been focused on resetting our foundation.

“This focus is intended to stabilise the business and strengthen our operational ability to build for a stronger future. In 2025, we made meaningful progress, despite our Q4 topline coming in softer than our expectations.”

Looking ahead to FY26, the company expects net sales and comparable sales to range from a 2% decline to flat on a YoY basis.

Adjusted operating margin is projected to be between 2.8% and 3.4%, while adjusted diluted earnings per share are forecast at $1 to $1.60.

Capital expenditure for the year is expected to be around $350m to $400m.

The board of directors has also declared a quarterly cash dividend of $0.125 per share on the company’s common stock, payable on 1 April 2026 to shareholders.

“Kohl’s FY25 profit rises despite lower net sales” was originally created and published by Retail Insight Network, a GlobalData owned brand.

 

The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.



Source link

Tags: FY25KohlsnetprofitRisessales
ShareTweetShare
Previous Post

Amazon Brand Happy Belly K-Cups 100-Count only $19.87 shipped! (Variety of roasts and flavors)

Next Post

Why the Market’s Fear Index Is Rising — And What History Says Happens Next

Related Posts

edit post
AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth .5B

AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5B

by TheAdviserMagazine
June 22, 2026
0

Insilico Medicine, the Hong Kong-listed AI drug discovery company, has signed a partnership with Korea’s SK Biopharmaceuticals to help develop...

edit post
US stocks: S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran

US stocks: S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran

by TheAdviserMagazine
June 22, 2026
0

The S&P 500 and the Nasdaq closed down on Monday, dragged lower by declines in the megacap technology stocks including...

edit post
52-year-old Outback Steakhouse rival chain closes 24 locations

52-year-old Outback Steakhouse rival chain closes 24 locations

by TheAdviserMagazine
June 22, 2026
0

Rising food costs driven by inflation have been a problem for U.S. steakhouses ranging from high-end to budget establishments, leading...

edit post
Anduril eyes former air force chief to head Israel operations

Anduril eyes former air force chief to head Israel operations

by TheAdviserMagazine
June 22, 2026
0

Anduril Industries cofounder Palmer Luckey wants to appoint former Israel Air Force Commander Gen. (res.) Amikam Norkin as head...

edit post
Australia scores its largest defense export ever with a .75 billion long-range radar deal with Canada

Australia scores its largest defense export ever with a $1.75 billion long-range radar deal with Canada

by TheAdviserMagazine
June 22, 2026
0

Australia and Canada signed a $1.75 billion export agreement on Monday to build an Australian-designed long-range radar system in Canada....

edit post
Ondas exec Meir Kliner: Defense sector must connect all solutions

Ondas exec Meir Kliner: Defense sector must connect all solutions

by TheAdviserMagazine
June 22, 2026
0

"Military superiority will be with whoever knows how to connect several autonomous systems under one roof. There is no...

Next Post
edit post
Why the Market’s Fear Index Is Rising — And What History Says Happens Next

Why the Market’s Fear Index Is Rising — And What History Says Happens Next

edit post
West Asia conflict poses downside risk, India GDP growth seen at 7.1 pc in FY27: Crisil Intelligence

West Asia conflict poses downside risk, India GDP growth seen at 7.1 pc in FY27: Crisil Intelligence

  • Trending
  • Comments
  • Latest
edit post
New York Seniors: 6 STAR Tax Relief Rules That Could Put a Bigger Check in Your Mailbox

New York Seniors: 6 STAR Tax Relief Rules That Could Put a Bigger Check in Your Mailbox

June 20, 2026
edit post
5 Pennsylvania Rebate Rules Seniors Should Check Before the Property Tax/Rent Deadline

5 Pennsylvania Rebate Rules Seniors Should Check Before the Property Tax/Rent Deadline

June 18, 2026
edit post
Florida Roads Become a Battleground for Illegal Immigration

Florida Roads Become a Battleground for Illegal Immigration

June 9, 2026
edit post
Louisiana’s Age-Tiered Homestead Exemption: 8 Details About the Proposed 2028 Amendment

Louisiana’s Age-Tiered Homestead Exemption: 8 Details About the Proposed 2028 Amendment

June 15, 2026
edit post
The 8 States That Still Tax Social Security in 2026

The 8 States That Still Tax Social Security in 2026

June 6, 2026
edit post
A Tax on Social Media – Blue-State Governments’ Newest Ploy

A Tax on Social Media – Blue-State Governments’ Newest Ploy

June 5, 2026
edit post
Ondas exec Meir Kliner: Defense sector must connect all solutions

Ondas exec Meir Kliner: Defense sector must connect all solutions

0
edit post
BiggerPockets Appoints Active Real Estate Investor Eric Augustyn as CEO, Ushering in a New Era of Platform Innovation

BiggerPockets Appoints Active Real Estate Investor Eric Augustyn as CEO, Ushering in a New Era of Platform Innovation

0
edit post
From Overwhelmed to Productive: Three Practical Strategies for First-Year Faculty – Faculty Focus

From Overwhelmed to Productive: Three Practical Strategies for First-Year Faculty – Faculty Focus

0
edit post
52-year-old Outback Steakhouse rival chain closes 24 locations

52-year-old Outback Steakhouse rival chain closes 24 locations

0
edit post
Mamdani Endorses in New York Dem Congressional Primaries

Mamdani Endorses in New York Dem Congressional Primaries

0
edit post
Are Tax Relief Companies Worth It? What to Know First

Are Tax Relief Companies Worth It? What to Know First

0
edit post
NIA Issues Hot-Weather Warning: Why Seniors Overheat Faster and How to Prevent Heat-Related Illnesses

NIA Issues Hot-Weather Warning: Why Seniors Overheat Faster and How to Prevent Heat-Related Illnesses

June 22, 2026
edit post
Bitcoin Funding Hits 2-week High: Are Bulls Back?

Bitcoin Funding Hits 2-week High: Are Bulls Back?

June 22, 2026
edit post
AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth .5B

AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5B

June 22, 2026
edit post
Boring is beautiful: why advisors are avoiding the bull market’s hype

Boring is beautiful: why advisors are avoiding the bull market’s hype

June 22, 2026
edit post
Fortive (FTV) Has a Recurring-Regulated-Tools and Software Story Bigger Than a Conglomerate Label

Fortive (FTV) Has a Recurring-Regulated-Tools and Software Story Bigger Than a Conglomerate Label

June 22, 2026
edit post
Nvidia’s stock struggles as Kalshi traders bet chip prices are coming down

Nvidia’s stock struggles as Kalshi traders bet chip prices are coming down

June 22, 2026
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • NIA Issues Hot-Weather Warning: Why Seniors Overheat Faster and How to Prevent Heat-Related Illnesses
  • Bitcoin Funding Hits 2-week High: Are Bulls Back?
  • AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5B
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.